Please login to the form below

Not currently logged in
Email:
Password:

Isis Pharmacueticals

This page shows the latest Isis Pharmacueticals news and features for those working in and with pharma, biotech and healthcare.

Roche and Isis in $392m deal to research drugs for brain disorder

Roche and Isis in $392m deal to research drugs for brain disorder

Will develop antisense drugs for Huntington's disease. Roche is to partner with Isis Pharmaceuticals to research medicines for the Huntington's disease – a rare, genetic brain disorder for which there ... The CHDI Foundation will receive $1.5m as part

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics